Statins and the Older Population: When Is It Beneficial and When Is It Not? - Frankly Speaking EP 96
Frankly Speaking About Family Medicine
November 26, 201810m 28s
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM.
Guest: Susan Feeney, DNP, FNP-BC
Landing Page: